|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 477/20 | |
| A61K 31/40 | |||
| A61K 31/407 |
| (11) | Number of the document | 1332145 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01934937.2 |
| Date of filing the European patent application | 2001-04-27 | |
| (97) | Date of publication of the European application | 2003-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2007-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/013794 |
| Date | 2001-04-27 |
| (87) | Number | WO 2002/034750 |
| Date | 2002-05-02 |
| (30) | Number | Date | Country code |
| 698808 | 2000-10-27 | US | |
| PCT/US00/29869 | 2000-10-27 | WO |
| (72) |
AL-DEHNEH, Anthony, US
HUNKE, William, A., US
ILLIG, Kathleen, J., US
KANIKE, Anand, US
PATEL, Hiren, US
REYNOLDS, Scott, D., US
TSINONTIDES, Stelios, C., US
|
| (73) |
Merck & Co., Inc.,
126 East Lincoln Avenue, Rahway, New Jersey 07065-0907,
US
|
| (54) | PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |
| PROCESS FOR FORMULATION OF ANTIBIOTIC COMPOUNDS |